Arrakis Therapeutics

Arrakis Therapeutics is a biotechnology company pioneering a new approach to drug discovery by targeting RNA with small molecules. Their mission is to unlock the vast and previously inaccessible realm of RNA biology, developing medicines that can modulate RNA function to address a wide range of diseases, including cancer, cardiovascular conditions, neurodegeneration, and rare diseases. This approach challenges traditional drug discovery methods, which primarily focus on protein targets, and offers the potential to treat diseases currently considered "undruggable."

Arrakis' platform leverages a deep understanding of RNA structure and function, employing both computational and experimental methods to identify and validate druggable RNA targets. They are developing a proprietary toolkit that includes advanced screening technologies, chemical biology tools like PEARL-seq, and bioinformatics algorithms for predicting RNA structure. Arrakis is committed to open science and has made some of their software tools publicly available, demonstrating their dedication to fostering collaboration within the scientific community.

Arrakis Therapeutics prioritizes employee needs and fosters a successful workplace through flexibility. They believe that flexibility is more than just a buzzword but a mindset that maximizes the value of life and work experiences while achieving optimal outcomes. The company trusts its employees, encourages open dialogue, and values individual accountability, creating an inclusive environment where everyone can thrive.

Arrakis Therapeutics is a biotechnology company pioneering a new era of RNA-targeted small molecule (rSM) medicines. Their mission is to unlock the vast potential of RNA biology by developing novel rSMs that address a wide range of diseases, including cancer, rare genetic diseases, and cardiovascular diseases. Arrakis aims to revolutionize drug discovery by expanding the universe of druggable targets beyond proteins, opening up new avenues for therapeutic intervention and ultimately improving the lives of millions of patients.

Arrakis Therapeutics promotes a culture of fearlessness, resilience, and humanity, encouraging its employees to embrace challenges, be supportive of one another, and value individual contributions. They foster an environment of collaboration and open dialogue, where everyone feels safe to share their opinions and ideas. This is reflected in their core values of being fearless, resilient, human, team-oriented, and inspired by each other, all contributing to a workplace where individuals can thrive and feel a sense of belonging.

Arrakis Therapeutics embraces diversity, equity, inclusion, and belonging (DEIB) as an integral part of its company culture. They have a dedicated DEIB committee with representation from all levels of the company, actively working to foster an inclusive environment where everyone feels valued, respected, and safe. This commitment extends beyond internal practices, as they actively engage in mentorship within their industry, partnering with local community groups, and participating in volunteer activities. Arrakis is dedicated to embedding DEIB into all aspects of their company, from recruiting and advancement to workplace culture, vendor selection, and employee engagement.